Marijuana breathalyzer stock symbol
Search stocks, ETFs and Commodities Price Quote as of. Today's Trading BLOZF) (the "Company" or "Cannabix") developer of marijuana breathalyzer devices for law enforcement and the Marijuana Breathalyzer Stock. Discussion. Close. 11. Posted by. u/somethingisrighthere. 3 years ago. Archived. Marijuana Breathalyzer Stock. Discussion. I strongly believe that this is a device that will be in every police car in the world in a few years. Does anyone know of a company that is creating one? Looking to invest now. Cannabix Technologies Inc (BLOZF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Looking for additional market data? Visit old.nasdaq.com Cannabix Technologies Inc., operates as technology company. The Company manufactures Marijuana breathalyzer. Cannabix Technologies serves in Canada.
Cannabix Technologies Inc., operates as technology company. The Company manufactures Marijuana breathalyzer. Cannabix Technologies serves in Canada.
1 Feb 2018 A majority of the largest pot stocks (those carrying a $200 million Cannabix's marijuana breathalyzer measures THC intoxication using breath Cannabix Technologies: 98% Speculation On This Marijuana Stock · Moneybags •Jan. Cannabix: Marijuana Breathalyzer Accuracy Not A Game Changer. 16 Nov 2017 Investors see big dividends if Cannabix brings the first Marijuana Breathalyzer to market. Cannabis Stocks Ancillary Market. Many regard has the exclusive North American license for the Cannabix Marijuana Breathalyzer. IPO Status Public Stock Symbol CNSX:BLO Company Type For Profit.
1 Feb 2018 A majority of the largest pot stocks (those carrying a $200 million Cannabix's marijuana breathalyzer measures THC intoxication using breath
Stock quote and company snapshot for CANNABIX TECHNOLOGIES INC (BLOZF), including profile, stock chart, recent news and events, analyst opinions, developer of marijuana breathalyzer devices for law enforcement and the workplace reports that a significant technological development has been achieved with its FAIMS- marijuana breathalyzer Search stocks, ETFs and Commodities Price Quote as of. Today's Trading BLOZF) (the "Company" or "Cannabix") developer of marijuana breathalyzer devices for law enforcement and the Marijuana Breathalyzer Stock. Discussion. Close. 11. Posted by. u/somethingisrighthere. 3 years ago. Archived. Marijuana Breathalyzer Stock. Discussion. I strongly believe that this is a device that will be in every police car in the world in a few years. Does anyone know of a company that is creating one? Looking to invest now. Cannabix Technologies Inc (BLOZF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Looking for additional market data? Visit old.nasdaq.com
20 Apr 2017 ticker symbol BLOZF. Here's what makes this company so interesting. Cannabix is racing to develop the world's first cannabis breathalyzer.
Cannabix Technologies, Inc. engages in the development and manufacturing of marijuana breathalyzer for law enforcement. It develops marijuana test devices to detect tetrahydrocannabinol using breath sample. The company was founded on April 5, 2011 and is headquartered in Burnaby, Canada. Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that a Hound Labs, Inc. operates as a scientific device company. The Company develops technology to detect and measure the levels of both marijuana and alcohol in a person's breath.
Hound Labs, Inc. operates as a scientific device company. The Company develops technology to detect and measure the levels of both marijuana and alcohol in a person's breath.
Cannabix Technologies Inc., operates as technology company. The Company manufactures Marijuana breathalyzer. Cannabix Technologies serves in Canada. Stock quotes and related data and links are provided for information purposes only and are not intended for trading purposes. Cannabix Technologies Inc. will not be liable for any inaccuracies or delays in such data, or for any actions taken in reliance thereon. Cannabis Stocks. Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022. The following publicly traded cannabis companies are not paid listings and are not recommendations to buy or sell any Marijuana Stocks listed here. All marijuana stocks on this page are organized in alphabetical order and each pot stock profile includes its full corporate name, stock ticker symbol, market cap, link to their corporate website as well as a link to their full profile on Marijuana Stocks (marijuanastocks.com). Marijuana Stock Industry Sectors. Let’s remember that the compelling investment thesis here is that when marijuana becomes legal everywhere, it will be consumed in much the same way alcohol is. Alcohol is an industry worth upwards of $200 billion in the United States alone. That’s why there is so much interest in marijuana stocks.
Cannabix Technologies Inc (BLOZF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Looking for additional market data? Visit old.nasdaq.com Cannabix Technologies Inc., operates as technology company. The Company manufactures Marijuana breathalyzer. Cannabix Technologies serves in Canada. Stock quotes and related data and links are provided for information purposes only and are not intended for trading purposes. Cannabix Technologies Inc. will not be liable for any inaccuracies or delays in such data, or for any actions taken in reliance thereon. Cannabis Stocks. Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022.